(KER) Kering - Overview

Sector: Consumer Cyclical | Industry: Luxury Goods | Exchange: PA (France) | Market Cap: 29.582m EUR | Total Return: 38.7% in 12m

Leather Goods, Fashion, Jewelry, Eyewear, Cosmetics
Total Rating 59
Safety 73
Buy Signal -0.41
Luxury Goods
Industry Rotation: -11.7
Market Cap: 34.4B
Avg Turnover: 55.4M
Risk 3d forecast
Volatility45.2%
VaR 5th Pctl7.46%
VaR vs Median0.22%
Reward TTM
Sharpe Ratio0.92
Rel. Str. IBD28.8
Rel. Str. Peer Group39.7
Character TTM
Beta0.721
Beta Downside1.021
Hurst Exponent0.493
Drawdowns 3y
Max DD69.50%
CAGR/Max DD-0.30
CAGR/Mean DD-0.50

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: KER Kering

Kering SA is a France-based global luxury group that designs, manufactures, and distributes apparel, leather goods, jewelry, and eyewear. Its portfolio includes high-end brands such as Gucci, Saint Laurent, Bottega Veneta, and Balenciaga, alongside specialized divisions like Kering Eyewear and Kering Beauté. The company operates through a multi-brand business model, centralizing shared resources such as logistics and supply chain management to improve margins across its diverse houses.

The luxury goods sector is characterized by high pricing power and significant barriers to entry due to established brand heritage and vertical integration of production. Kering generates revenue across major international markets, including Asia Pacific, Western Europe, and North America, catering to both the mature and emerging affluent consumer segments. Investors can examine the companys valuation metrics further on ValueRay to better understand its market position. Originally founded in 1963 as PPR SA, the firm transitioned its focus exclusively to the luxury segment before rebranding to Kering in 2013.

Headlines to Watch Out For
  • Gucci brand turnaround performance determines overall group revenue growth and margins
  • Chinese luxury consumer demand volatility impacts core leather goods sales
  • Strategic expansion into high-margin beauty and eyewear categories diversifies earnings
  • Elevated marketing spend for brand elevation initiatives pressures short-term operating margins
  • Global interest rate environment influences discretionary spending on high-end fashion houses
Piotroski VR-10 (Strict) 7.0
Net Income: 1.21b TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.07 > 1.0
NWC/Revenue: 8.49% < 20% (prev 11.00%; Δ -2.51% < -1%)
CFO/TA 0.16 > 3% & CFO 6.68b > Net Income 1.21b
Net Debt (25.5b) to EBITDA (11.2b): 2.28 < 3
Current Ratio: 1.34 > 1.5 & < 3
Outstanding Shares: last quarter (122.9m) vs 12m ago 0.39% < -2%
Gross Margin: 73.24% > 18% (prev 0.76%; Δ 7.25k% > 0.5%)
Asset Turnover: 77.21% > 50% (prev 72.49%; Δ 4.72% > 0%)
Interest Coverage Ratio: 5.62 > 6 (EBITDA TTM 11.2b / Interest Expense TTM 1.25b)
Altman Z'' 2.80
A: 0.07 (Total Current Assets 10.8b - Total Current Liabilities 8.05b) / Total Assets 41.2b
B: 0.36 (Retained Earnings 14.9b / Total Assets 41.2b)
C: 0.17 (EBIT TTM 7.03b / Avg Total Assets 41.3b)
D: 0.05 (Book Value of Equity 1.16b / Total Liabilities 25.7b)
Altman-Z'' = 2.80 = A
Beneish M -2.96
DSRI: 1.07 (Receivables 1.31b/1.15b, Revenue 31.9b/30.0b)
GMI: 1.04 (GM 73.24% / 75.86%)
AQI: 1.12 (AQ_t 0.52 / AQ_t-1 0.46)
SGI: 1.06 (Revenue 31.9b / 30.0b)
TATA: -0.13 (NI 1.21b - CFO 6.68b) / TA 41.2b)
Beneish M = -2.96 (Cap -4..+1) = A
What is the price of KER shares?

As of May 25, 2026, the stock is trading at EUR 242.00 with a total of 218,604 shares traded.
Over the past week, the price has changed by +2.17%, over one month by +0.81%, over three months by -15.12% and over the past year by +38.65%.

Is KER a buy, sell or hold?

Kering has no consensus analysts rating.

Kering (KER) - Fundamental Data Overview as of 20 May 2026
Market Cap USD = 34.4b (29.6b EUR * 1.1641 EUR.USD)
P/E Forward = 37.7358
P/S = 2.0158
P/B = 2.0503
P/EG = 1.1239
Revenue TTM = 31.9b EUR
EBIT TTM = 7.03b EUR
EBITDA TTM = 11.2b EUR
Long Term Debt = 10.3b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.23b EUR (from shortTermDebt, last quarter)
Debt = 29.8b EUR (from shortLongTermDebtTotal, last quarter) + Leases 6.21b
Net Debt = 25.5b EUR (calculated: Debt 29.8b - CCE 4.31b)
Enterprise Value = 55.1b EUR (29.6b + Debt 29.8b - CCE 4.31b)
Interest Coverage Ratio = 5.62 (Ebit TTM 7.03b / Interest Expense TTM 1.25b)
EV/FCF = 17.95x (Enterprise Value 55.1b / FCF TTM 3.07b)
FCF Yield = 5.57% (FCF TTM 3.07b / Enterprise Value 55.1b)
FCF Margin = 9.63% (FCF TTM 3.07b / Revenue TTM 31.9b)
Net Margin = 3.78% (Net Income TTM 1.21b / Revenue TTM 31.9b)
Gross Margin = 73.24% ((Revenue TTM 31.9b - Cost of Revenue TTM 8.53b) / Revenue TTM)
Gross Margin QoQ = 72.25% (prev 73.01%)
Tobins Q-Ratio = 1.34 (Enterprise Value 55.1b / Total Assets 41.2b)
Interest Expense / Debt = 4.20% (Interest Expense 1.25b / Debt 29.8b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 5.27b (EBIT 7.03b * (1 - 25.00%))
Current Ratio = 1.34 (Total Current Assets 10.8b / Total Current Liabilities 8.05b)
Debt / Equity = 2.03 (Debt 29.8b / totalStockholderEquity, last quarter 14.7b)
Debt / EBITDA = 2.28 (Net Debt 25.5b / EBITDA 11.2b)
Debt / FCF = 8.31 (Net Debt 25.5b / FCF TTM 3.07b)
Total Stockholder Equity = 14.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 1.21b / Total Assets 41.2b)
RoE = 8.13% (Net Income TTM 1.21b / Total Stockholder Equity 14.8b)
RoCE = 27.99% (EBIT 7.03b / Capital Employed (Equity 14.8b + L.T.Debt 10.3b))
RoIC = 16.46% (NOPAT 5.27b / Invested Capital 32.0b)
WACC = 5.83% (E(29.6b)/V(59.4b) * Re(8.53%) + D(29.8b)/V(59.4b) * Rd(4.20%) * (1-Tc(0.25)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -33.33 | Cagr: -0.66%
[DCF] Terminal Value 77.97% ; FCFF base≈2.40b ; Y1≈2.75b ; Y5≈4.05b
[DCF] Fair Price = 289.3 (EV 61.0b - Net Debt 25.5b = Equity 35.5b / Shares 122.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -82.32 | EPS CAGR: -62.94% | SUE: N/A | # QB: 0
Revenue Correlation: -99.57 | Revenue CAGR: -12.83% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=6.58 | Chg30d=-1.19% | Revisions=-33% | GrowthEPS=+51.9% | GrowthRev=+0.3%
EPS next Year (2027-12-31): EPS=9.92 | Chg30d=-0.21% | Revisions=-17% | GrowthEPS=+50.7% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: -33%